Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
4
×
biotech
boston blog main
4
×
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
cancer
eli lilly
glaxosmithkline
startups
amgen
astrazeneca
biogen
black diamond therapeutics
What
bio
roundup
black
diamond’s
drugs
acquisitions
announced
appetite
august
biotech
bread
busy
butter
buyout
cancer
cash
ceo
collabs
companies
continue
covid
daniel
days
deal
debut
decisions
devices
diabetes
diamond
eli
fda
giant
gilead
gilead’s
grabbed
hasn’t
help
hold
indication
introduce
Language
unset
Current search:
ipo
×
allergan
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More